Skip to content

Syed Basit Haider, MBBS

NPI 1134879034ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Milwaukee, WI

Internal Medicine, Endocrinology, Diabetes & Metabolism (MBBS) in Milwaukee, Wisconsin, licensed in WI, with an NPI issued in March 2022. Part D covered 60 prescriptions written in 2024, 87% of them generic. Gilead Sciences, Inc. reported $26.37 in payments in 2025, mostly food and beverage.

Overview

NPI1134879034
StatusActive
Entity typeIndividual
CredentialMBBS
Sole proprietorNo
NPI issuedMar 24, 2022
Last updated in NPPESJun 29, 2025
Certified by providerJun 29, 2025

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (TX)

Part D prescriptions in 2024

Prescriptions (claims)60 · 91 30-day fills
Patients31
Total drug cost$7,750
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$26.37 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Gilead Sciences, Inc.$26.371

What the 2025 payments were for

  • Food and Beverage$26.37 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Milwaukee

All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Wisconsin →